Dermatologic manifestations and diagnostic assessments of the Ehlers-Danlos syndromes: A clinical review

Background: The Ehlers-Danlos syndromes (EDSs) comprise a group of connective tissue disorders that manifest with skin hyperextensibility, easy bruising, joint hypermobility and fragility of skin, soft tissues, and some organs. A correct assessment of cutaneous features along with the use of adjunct technologies can improve diagnostic accuracy.Objectives: To systematically review the cutaneous features and adjunct investigations of EDS. Methods: A search of PubMed and Web of Science for EDS-related cutaneous features and additional investigations was undertaken from publication of the 2017 International Classification of EDS until January 15, 2022.Results: One-hundred-and-forty studies involved 839 patients with EDS. The EDS female-to-male ratio was 1.36:1 (P \ .001). A high prevalence of skin hyperextensibility, bruising, and soft skin were noted. Most patients with vascular Ehlers-Danlos syndrome showed venous visibility, skin fragility, and acrogeria. Classical EDS showed subcutaneous spheroids and molluscoid pseudotumours. In patients that underwent skin biopsies, only 30.3% and 71.4% showed features suggestive of EDS using light microscopy and transmission electron microscopy, respectively. Limitations: Retrospective study and small cases numbers for some EDS-subtypes.Conclusions: An accurate clinical diagnosis increases the chances of a molecular diagnosis, particularly for rarer EDS subtypes, whilst decreasing the need for genetic testing where there is a low clinical suspicion for a monogenic EDS-subtype. ( J Am Acad Dermatol 2023;89:551-9.)

Automated summary

This study systematically reviewed the cutaneous features and adjunct investigations of Ehlers-Danlos syndromes (EDS). The study found that EDS patients often exhibit skin hyperextensibility, easy bruising, and skin fragility. Skin biopsies showed that only 30.3% and 71.4% of patients exhibited features suggestive of EDS using light microscopy and transmission electron microscopy, respectively. An accurate clinical diagnosis can increase the chances of a molecular diagnosis and reduce the need for genetic testing in low clinical suspicion cases.